Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 18.391
Filter
1.
Nan Fang Yi Ke Da Xue Xue Bao ; 44(4): 617-626, 2024 Apr 20.
Article in Chinese | MEDLINE | ID: mdl-38708493

ABSTRACT

OBJECTIVE: To investigate immunogenic and toxic effects of graphene oxide (GO) nanoparticles in mouse skeletal muscles and in human blood in vitro. METHODS: GO nanoparticles prepared using a probe sonicator were supended in deionized H2O or PBS, and particle size and surface charge of the nanoparticles were measured with dynamic light scattering (DLS). Different concentrations (0.5, 1.0 and 2.0 mg/mL) of GO suspension or PBS were injected at multiple sites in the gastrocnemius muscle (GN) of C57BL/6 mice, and inflammatory response and immune cell infiltrations were detected with HE and immunofluorescence staining. We also examined the effects of GO nanoparticles on human red blood cell (RBC) morphology, hemolysis and blood coagulation using scanning electron microscope (SEM), spectrophotometry, and thromboelastography (TEG). RESULTS: GO nanoparticles suspended in PBS exhibited better colloidal dispersity, stability and surface charge effects than those in deionized H2O. In mouse GNs, injection of GO suspensions dose- and time-dependently resulted in sustained muscular inflammation and myofiber degeneration at the injection sites, which lasted till 8 weeks after the injection; immunofluorescence staining revealed obvious infiltration of monocytes, macrophages, dendritic cells and CD4+ T cells around the injection sites in mouse GNs. In human RBCs, incubation with GO suspensions at 0.2, 2.0 and 20 mg/mL, but not at 0.002 or 0.02 mg/mL, caused significant alterations of cell morphology and hemolysis. TEG analysis showed significant abnormalities of blood coagulation parameters following treatment with high concentrations of GO. CONCLUSION: GO nanoparticles can induce sustained inflammatory and immunological responses in mouse GNs and cause RBC hemolysis and blood coagulation impairment, suggesting its muscular toxicity and hematotoxicity at high concentrations.


Subject(s)
Erythrocytes , Graphite , Hemolysis , Mice, Inbred C57BL , Muscle, Skeletal , Nanoparticles , Animals , Graphite/toxicity , Graphite/chemistry , Mice , Erythrocytes/drug effects , Humans , Muscle, Skeletal/drug effects , Hemolysis/drug effects , Particle Size , Blood Coagulation/drug effects
2.
Sci Rep ; 14(1): 10561, 2024 05 08.
Article in English | MEDLINE | ID: mdl-38719884

ABSTRACT

This study focuses on understanding the structural and molecular changes in lipid membranes under the influence of six halogenated flavonoid derivatives differing in the number and position of substitution of chlorine and bromine atoms (D1-D6). Utilizing various analytical techniques, including fluorometric methods, dynamic light scattering (DLS), attenuated Fourier transform infrared spectroscopy (ATR- FTIR), and FT-Raman spectroscopy, the research aims to elucidate the mechanisms underlying the interaction of flavonoids with cell membranes. Additionally, the study includes in silico analyses to explore the physicochemical properties of these compounds and their potential pharmaceutical applications, along with toxicity studies to assess their effects on cancer, normal, and red blood cells. Our study showed the ability of halogenated derivatives to interact mostly with the outer part of the membrane, especially in the lipid heads region however, some of them were able to penetrate deeper into the membrane and affect the fluidity of hydrocarbon chains. The potential to reduce cancer cell viability, the lack of toxicity towards erythrocytes, and the favourable physicochemical and pharmacokinetic properties suggest these halogenated flavonoids potential candidates for exploring their potential for medical use.


Subject(s)
Flavonoids , Membrane Lipids , Flavonoids/chemistry , Flavonoids/pharmacology , Flavonoids/metabolism , Humans , Membrane Lipids/metabolism , Membrane Lipids/chemistry , Cell Membrane/metabolism , Halogenation , Cytotoxins/chemistry , Cytotoxins/pharmacology , Cytotoxins/metabolism , Erythrocytes/drug effects , Erythrocytes/metabolism , Cell Survival/drug effects , Spectrum Analysis, Raman , Spectroscopy, Fourier Transform Infrared , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Cell Line, Tumor
3.
Arch Microbiol ; 206(6): 257, 2024 May 11.
Article in English | MEDLINE | ID: mdl-38734773

ABSTRACT

There is a growing imperative for research into alternative compounds for the treatment of the fungal infections. Thus, many studies have focused on the analysis of antifungal proteins and peptides from different plant sources. Among these molecules are protease inhibitors (PIs). Previously, PIs present in the peptide-rich fractions called PEF1, PEF2 and PEF3 were identified from Capsicum chinense seeds, which have strong activity against phytopathogenic fungi. The aim of this study was to evaluate the mechanism of action and antimicrobial activity of PIs from PEF2 and PEF3 on the growth of yeasts of the genus Candida. In this work, analyses of their antimicrobial activity and cell viability were carried out. Subsequently, the mechanism of action by which the PIs cause the death of the yeasts was evaluated. Cytotoxicity was assessed in vitro by erythrocytes lysis and in vivo in Galleria mellonella larvae. PEF2 and PEF3 caused 100% of the growth inhibition of C. tropicalis and C. buinensis. For C. albicans inhibition was approximately 60% for both fractions. The PEF2 and PEF3 caused a reduction in mitochondrial functionality of 54% and 46% for C. albicans, 26% and 30% for C. tropicalis, and 71% and 68% for C. buinensis, respectively. These fractions induced morphological alterations, led to membrane permeabilization, elevated ROS levels, and resulted in necrotic cell death in C. tropicalis, whilst demonstrating low toxicity toward host cells. From the results obtained here, we intend to contribute to the understanding of the action of PIs in the control of fungal diseases of medical importance.


Subject(s)
Antifungal Agents , Candida , Protease Inhibitors , Antifungal Agents/pharmacology , Candida/drug effects , Candida/growth & development , Protease Inhibitors/pharmacology , Microbial Sensitivity Tests , Animals , Capsicum/microbiology , Reactive Oxygen Species/metabolism , Seeds/growth & development , Plant Extracts/pharmacology , Plant Extracts/chemistry , Erythrocytes/drug effects , Larva/microbiology , Larva/growth & development , Larva/drug effects
4.
J Ethnopharmacol ; 331: 118280, 2024 Sep 15.
Article in English | MEDLINE | ID: mdl-38714239

ABSTRACT

ETHNO-PHARMACOLOGICAL RELEVANCE: Globally, the prevalence of sickle cell disease is on the rise, with developing countries experiencing particularly alarming mortality rate compared to developed nations. The World Health Organization (WHO) and United Nations (UN) have acknowledged sickle cell disease as a significant global public health concern. Unfortunately, a cure for this condition is yet to be discovered, and existing allopathic treatments, while offering relief, come with serious side effects. In recent times, there has been a growing interest in exploring the potential of medicinal plants for treating sickle cell disease due to their content of secondary metabolites that may impact the disease's mechanisms. Cajanus cajan, a crucial grain legume in rain-fed agriculture in semi-arid tropics, has been traditionally used in folk medicine to manage various illnesses and is suggested to possess anti-sickling properties. AIM OF THE STUDY: The present study investigated two varieties of C. cajan for their effectiveness in treating sickle cell beta thalassemia, a variant of sickle cell disease. MATERIALS AND METHODS: The study was divided into four groups consisting of the untreated group (group 1), group treated with standard drug (group 2), group treated with white C. cajan (group 3) and group treated with brown C. cajan (group 4). The effects of the two variety of C. cajan were measured by polymerization test, reversibility test, osmotic fragility test, deoxygenation and beta globin synthesis test. RESULT: The results revealed that both varieties of C. cajan demonstrated a reduction in polymerization rates, reversed sickled red blood cells, increased the oxygen affinity of Hb-S/ß, elevated the Fe2+/Fe3+ ratio, and maintained the membrane stability of red blood cells. Notably, the white variety exhibited superior anti-sickling properties compared to the brown variety. CONCLUSION: This suggests that this significant leguminous crop could be utilized for the treatment and management of sickling disorders, particularly in low-income countries where conventional treatments may be financially inaccessible to patients.


Subject(s)
Antisickling Agents , Cajanus , Plant Extracts , beta-Thalassemia , Cajanus/chemistry , Humans , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Antisickling Agents/therapeutic use , Antisickling Agents/pharmacology , Anemia, Sickle Cell/drug therapy , Erythrocytes/drug effects , Erythrocytes/metabolism , Phytotherapy
5.
Biochim Biophys Acta Biomembr ; 1866(5): 184331, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38718958

ABSTRACT

The causative genes for neurodegenerative polyglutamine (polyQ) diseases produce homopolymeric polyglutamine (polyQ), polyserine (polyS), polyalanine (polyA), polycysteine (polyC), and polyleucine (polyL) sequences by repeat-associated non-AUG (RAN) translation. The cytotoxicity of the intracellular polyQ and RAN products has been extensively investigated. However, little is known about the toxicity of the extracellular polyQ and RAN products on the membranes of viable cells. Because polyQ aggregates induce a deflated morphology of a model membrane, we hypothesized that extracellular polyQ and RAN products might affect the membrane properties of viable cells. In this study, we demonstrated that exogenous polyS fibrils but not polyS or polyQ non-fibril aggregates altered the thermal phase transition behavior of a model membrane composed of a phosphatidylcholine bilayer using differential scanning calorimetry. PolyS fibrils induced morphological changes in viable red blood cells (RBCs). However, both polyS and polyQ non-fibril aggregates had no effects on RBCs. These results highlight the possibility that extracellular fibrils generated from RAN products may alter the properties of neuronal cell membranes, which may contribute to changes in the brain pathology.


Subject(s)
Erythrocytes , Liposomes , Peptides , Phosphatidylcholines , Erythrocytes/drug effects , Erythrocytes/metabolism , Phosphatidylcholines/chemistry , Humans , Liposomes/chemistry , Peptides/chemistry , Peptides/pharmacology , Cell Membrane/metabolism , Cell Membrane/drug effects , Cell Membrane/chemistry , Phase Transition , Lipid Bilayers/chemistry , Lipid Bilayers/metabolism
6.
Dokl Biol Sci ; 516(1): 50-54, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38700814

ABSTRACT

The content of membrane-bound methemoglobin (MtHb) in nucleated erythrocytes was studied in the black scorpionfish Scorpaena porcus (Linnaeus, 1758) in vitro. Spectral characteristics were determined for a whole hemolysate, a hemolysate obtained by stroma precipitation (a clarified hemolysate), and a resuspended stroma. The MtHb proportion in the erythrocyte stroma was found to exceed 80% (6.20 ± 0.59 µM). Clarified hemolysates were nearly free of MtHb (0.5 ± 0.2 µM). Membrane-bound ferric hemoglobin did not affect the erythrocyte resistance to osmotic shock. The osmotic fragility range was determined using a LaSca-TM laser microparticle analyzer (BioMedSystems, Russia) to be 102-136 mOsm/kg, much the same as in other bony fish species. A nitrite load (10 mg/L) significantly increased the MtHb content in the blood. However, the membrane-bound ferric hemoglobin content did not change significantly, amounting to 6.34 ± 1.09 µM (approximately 95%). The finding suggested a functional importance for MtHb present in the plasma membrane of nucleated erythrocytes. Membrane-bound MtHb was assumed to neutralize the external oxidative load and the toxic effect of hydrogen sulfide in bottom water layers, where the species lives.


Subject(s)
Methemoglobin , Perciformes , Animals , Methemoglobin/metabolism , Perciformes/metabolism , Perciformes/blood , Hemoglobins/metabolism , Osmotic Fragility , Erythrocyte Membrane/metabolism , Erythrocyte Membrane/drug effects , Erythrocytes/metabolism , Erythrocytes/drug effects , Erythroblasts/metabolism , Fishes/metabolism , Fishes/blood
7.
Transfusion ; 64(6): 1097-1108, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38716879

ABSTRACT

BACKGROUND: N-(-9 acridinyl)-b-alanine hydrochloride (S-300) is the main byproduct of red blood cell (RBC) amustaline/glutathione(GSH) pathogen reduction, currently undergoing phase III US clinical trials following successful European studies(1-3). Phosphatidylinositol glycan, class A (Pig-a) X-linked gene mutagenesis is a validated mammalian in vivo mutation assay for genotoxicity, assessed as clonal loss of glycosylphosphatidylinositol-linked CD59 cell-surface molecules on reticulocytes (RETs) and RBCs. METHODS: Male Sprague-Dawley rats received continuous infusion of S-300 up to the maximum feasible dose (240 mg/kg/day-limited by solubility and volume) for 28 days. Positive controls received a known mutagen by oral gavage on Days 1-3. Plasma levels of S-300 were assessed by HPLC before, during and after infusion. CD59-negative RBCs and RETs were enumerated in pre-dose and Day 28 samples, using a flow cytometric method. Outcome was evaluated by predetermined criteria using concurrent and historical controls. Toxicity was assessed by laboratory measures and necropsy. RESULTS: S-300 reached maximum, dose-dependent levels (3-15 µmol/L) within 2-8 h that were sustained for 672 h and undetectable 2 h after infusion. Circulating RET levels indicated a lack of hematopoietic toxicity. Necropsy revealed minimal-mild observations related to poor S-300 solubility at high concentrations. Pig-a assessment met the preset acceptability criteria and revealed no increase in mutant RBCs or RETs. CONCLUSIONS: Maximum feasible S-300 exposure of rats by continuous infusion for 28 days was not genotoxic as assessed by an Organization for Economic Cooperation and Development-compliant, mammalian, in vivo Pig-a gene mutation assay that meets the requirements of International Conference on Harmonization (ICH) S2(R1) and FDA guidances on genotoxicity testing.


Subject(s)
Mutagenicity Tests , Rats, Sprague-Dawley , Animals , Male , Rats , Mutagenicity Tests/methods , CD59 Antigens/genetics , Reticulocytes/drug effects , Erythrocytes/drug effects , Erythrocytes/metabolism , Membrane Proteins/genetics , Mutagenesis/drug effects , Mutagens/toxicity
8.
Int J Mol Sci ; 25(10)2024 May 14.
Article in English | MEDLINE | ID: mdl-38791402

ABSTRACT

Alkaloids are natural compounds useful as scaffolds for discovering new bioactive molecules. This study utilized alkaloid gramine to synthesize two groups of C3-substituted indole derivatives, which were either functionalized at N1 or not. The compounds were characterized by spectroscopic methods. The protective effects of the new compounds against in vitro oxidative hemolysis induced by standard oxidant 2,2'-azobis(2-amidinopropane dihydro chloride (AAPH) on human erythrocytes as a cell model were investigated. Additionally, the compounds were screened for antimicrobial activity. The results indicated that most of the indole derivatives devoid of the N1 substitution exhibited strong cytoprotective properties. The docking studies supported the affinities of selected indole-based ligands as potential antioxidants. Furthermore, the derivatives obtained exhibited potent fungicidal properties. The structures of the eight derivatives possessing indole moiety bridged to the imidazole-, benzimidazole-, thiazole-, benzothiazole-, and 5-methylbenzothiazoline-2-thiones were determined by X-ray diffraction. The C=S bond lengths in the thioamide fragment pointed to the involvement of zwitterionic structures of varying contribution. The predominance of zwitterionic mesomers may explain the lack of cytoprotective properties, while steric effects, which limit multiple the hydrogen-bond acceptor properties of a thione sulfur, seem to be responsible for the high hemolytic activity.


Subject(s)
Erythrocytes , Hemolysis , Indoles , Humans , Hemolysis/drug effects , Indoles/chemistry , Indoles/pharmacology , Erythrocytes/drug effects , Molecular Docking Simulation , Anti-Infective Agents/pharmacology , Anti-Infective Agents/chemistry , Structure-Activity Relationship , Antioxidants/pharmacology , Antioxidants/chemistry , Microbial Sensitivity Tests , Cytoprotection/drug effects , Amidines
9.
Int J Mol Sci ; 25(10)2024 May 08.
Article in English | MEDLINE | ID: mdl-38791153

ABSTRACT

Garlic is known to have diverse effects on mammalian cells, being cytotoxic, especially to cancer cells, but also protect against oxidative stress. Mammalian erythrocyte is a simple cell devoid of intracellular organelles, protein synthesis ability, and most signaling pathways. Therefore, examination of the effects of garlic on erythrocytes allows for revealing primary events in the cellular action of garlic extract. In this study, human erythrocytes or erythrocyte membranes were exposed to garlic extract at various dilutions. Hemoglobin oxidation to methemoglobin, increased binding of hemoglobin to the membrane, and formation of Heinz bodies were observed. Garlic extract depleted acid-soluble thiols, especially glutathione, and induced a prooxidative shift in the cellular glutathione redox potential. The extract increased the osmotic fragility of erythrocytes, induced hemolysis, and inhibited hemolysis in isotonic ammonium chloride, indicative of decreased membrane permeability for Cl- and increased the membrane fluidity. Fluorescent probes indicated an increased level of reactive oxygen species and induction of lipid peroxidation, but these results should be interpreted with care since the extract alone induced oxidation of the probes (dichlorodihydrofluorescein diacetate and BODIPY C11). These results demonstrate that garlic extract induces oxidative changes in the erythrocyte, first of all, thiol and hemoglobin oxidation.


Subject(s)
Erythrocytes , Garlic , Hemolysis , Oxidation-Reduction , Plant Extracts , Garlic/chemistry , Humans , Plant Extracts/pharmacology , Erythrocytes/drug effects , Erythrocytes/metabolism , Hemolysis/drug effects , Oxidation-Reduction/drug effects , Lipid Peroxidation/drug effects , Hemoglobins/metabolism , Erythrocyte Membrane/drug effects , Erythrocyte Membrane/metabolism , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Glutathione/metabolism , Osmotic Fragility/drug effects
10.
Int J Biol Macromol ; 269(Pt 2): 132257, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38729492

ABSTRACT

Low-density lipoprotein (LDL) transports cholesterol to various tissues via the blood. Glycation of LDL occurs during hyperglycemic condition which is characterised by persistently high blood glucose level. Circulating erythrocytes can come in direct contact with glycated LDL (G-LDL). The objective of this study was to investigate the effect of G-LDL on human erythrocytes, specifically on hemoglobin, intracellular generation of reactive species and the antioxidant defence system. Isolated erythrocytes were incubated with G-LDL (3 and 6 mg/ml) and native LDL (6 mg/ml) at 37 °C for 24 h. Native LDL and G-LDL untreated erythrocytes were similarly incubated at 37 °C and served as control. G-LDL treatment increased hemolysis compared to control and native LDL-treated erythrocytes. Incubation of erythrocytes with G-LDL led to an increase in protein oxidation and lipid peroxidation while greatly decreasing the total sulfhydryl content. It also significantly enhanced hemoglobin oxidation, heme degradation, and the release of free iron moiety. Treatment with G-LDL led to an appreciable increase in the production of reactive oxygen and nitrogen species. The antioxidant power and activities of major antioxidant enzymes were drastically reduced, while critical membrane-bound enzymes were inhibited. The surface morphology of G-LDL-treated erythrocytes was altered leading to the formation of echinocytes. Importantly, treatment of erythrocytes with native LDL did not significantly affect the above-mentioned parameters and values were similar to the corresponding controls. Thus, G-LDL is cytotoxic to human erythrocytes and causes oxidative damage to cell components. This can reduce the oxygen-transporting ability of blood and also result in red cell senescence and anemia.


Subject(s)
Erythrocytes , Hemoglobins , Hemolysis , Lipoproteins, LDL , Oxidation-Reduction , Reactive Oxygen Species , Humans , Erythrocytes/metabolism , Erythrocytes/drug effects , Lipoproteins, LDL/metabolism , Lipoproteins, LDL/pharmacology , Reactive Oxygen Species/metabolism , Hemoglobins/metabolism , Hemolysis/drug effects , Oxidation-Reduction/drug effects , Antioxidants/pharmacology , Lipid Peroxidation/drug effects , Glycation End Products, Advanced/metabolism , Glycation End Products, Advanced/pharmacology , Oxidative Stress/drug effects , Heme/metabolism , Heme/pharmacology , Glycated Proteins
11.
Int J Mol Sci ; 25(10)2024 May 10.
Article in English | MEDLINE | ID: mdl-38791223

ABSTRACT

Amyloid beta peptides (Aß) have been identified as the main pathogenic agents in Alzheimer's disease (AD). Soluble Aß oligomers, rather than monomer or insoluble amyloid fibrils, show red blood cell (RBC) membrane-binding capacity and trigger several morphological and functional alterations in RBCs that can result in impaired oxygen transport and delivery. Since bioactive lipids have been recently proposed as potent protective agents against Aß toxicity, we investigated the role of sphingosine-1-phosphate (S1P) in signaling pathways involved in the mechanism underlying ATP release in Ab-treated RBCs. In RBCs following different treatments, the ATP, 2,3 DPG and cAMP levels and caspase 3 activity were determined by spectrophotometric and immunoassay. S1P rescued the inhibition of ATP release from RBCs triggered by Ab, through a mechanism involving caspase-3 and restoring 2,3 DPG and cAMP levels within the cell. These findings reveal the molecular basis of S1P protection against Aß in RBCs and suggest new therapeutic avenues in AD.


Subject(s)
Adenosine Triphosphate , Amyloid beta-Peptides , Caspase 3 , Cyclic AMP , Erythrocytes , Lysophospholipids , Sphingosine , Lysophospholipids/metabolism , Sphingosine/analogs & derivatives , Sphingosine/metabolism , Amyloid beta-Peptides/metabolism , Erythrocytes/metabolism , Erythrocytes/drug effects , Humans , Cyclic AMP/metabolism , Adenosine Triphosphate/metabolism , Caspase 3/metabolism , Alzheimer Disease/metabolism , Alzheimer Disease/drug therapy , 2,3-Diphosphoglycerate/metabolism , Signal Transduction/drug effects
12.
Sci Rep ; 14(1): 12317, 2024 05 29.
Article in English | MEDLINE | ID: mdl-38811619

ABSTRACT

COVID-19 infection is associated with a variety of vascular occlusive morbidities. However, a comprehensive understanding of how this virus can induce vascular complications remains lacking. Here, we show that a peptide fragment of SARS-CoV-2 spike protein, S192 (sequence 192-211), is capable of forming amyloid-like aggregates that can induce agglutination of red blood cells, which was not observed with low- and non-aggregated S192 peptide. We subsequently screened eight amyloid-binding molecules and identified BAM1-EG6, a benzothiazole amphiphile, as a promising candidate capable of binding to aggregated S192 and partially inhibiting its agglutination activity. These results provide new insight into a potential molecular mechanism for the capability of spike protein metabolites to contribute to COVID-19-related blood complications and suggest a new therapeutic approach for combating microvascular morbidities in COVID-19 patients.


Subject(s)
Benzothiazoles , COVID-19 , Hemagglutination , SARS-CoV-2 , Spike Glycoprotein, Coronavirus , Spike Glycoprotein, Coronavirus/metabolism , Spike Glycoprotein, Coronavirus/chemistry , Humans , Benzothiazoles/chemistry , Benzothiazoles/pharmacology , SARS-CoV-2/drug effects , SARS-CoV-2/metabolism , COVID-19/virology , COVID-19/metabolism , Hemagglutination/drug effects , Amyloid/metabolism , Protein Binding , Erythrocytes/metabolism , Erythrocytes/drug effects , Erythrocytes/virology , Peptide Fragments/metabolism , Peptide Fragments/chemistry , Peptide Fragments/pharmacology
13.
Sci Rep ; 14(1): 9381, 2024 04 23.
Article in English | MEDLINE | ID: mdl-38654085

ABSTRACT

Erythrocytes are impressive tools for drug delivery, especially to macrophages. Therefore, berberine was loaded into erythrocytes using both hypotonic pre-swelling and endocytosis methods to target macrophages. Physicochemical and kinetic parameters of the resulting carrier cells, such as drug loading/release kinetics, osmotic fragility, and hematological indices, were determined. Drug loading was optimized for the study using Taguchi experimental design and lab experiments. Loaded erythrocytes were targeted to macrophages using ZnCl2 and bis-sulfosuccinimidyl-suberate, and targeting was evaluated using flow cytometry and Wright-Giemsa staining. Differentiated macrophages were stimulated with lipopolysaccharide, and the inflammatory profiles of macrophages were evaluated using ELISA, western blotting, and real-time PCR. Findings indicated that the endocytosis method is preferred due to its low impact on the erythrocyte's structural integrity. Maximum loading achieved (1386.68 ± 22.43 µg/ml) at 1500 µg/ml berberine treatment at 37 °C for 2 h. Berberine successfully inhibited NF-κB translation in macrophages, and inflammatory response markers such as IL-1ß, IL-8, IL-23, and TNF-α were decreased by approximately ninefold, sixfold, twofold, eightfold, and twofold, respectively, compared to the LPS-treated macrophages. It was concluded that berberine-loaded erythrocytes can effectively target macrophages and modulate the inflammatory response.


Subject(s)
Berberine , Cytokines , Erythrocytes , Macrophages , Berberine/pharmacology , Berberine/administration & dosage , Erythrocytes/metabolism , Erythrocytes/drug effects , Macrophages/metabolism , Macrophages/drug effects , Cytokines/metabolism , Animals , Mice , Lipopolysaccharides/pharmacology , RAW 264.7 Cells , NF-kappa B/metabolism , Inflammation/metabolism , Inflammation/drug therapy
14.
Sci Rep ; 14(1): 9624, 2024 04 26.
Article in English | MEDLINE | ID: mdl-38671030

ABSTRACT

Fernandoa adenophylla, due to the presence of phytochemicals, has various beneficial properties and is used in folk medicine to treat many conditions. This study aimed to isolate indanone derivative from F. adenophylla root heartwood and assess in-vitro anti-inflammatory and anti-diabetic characteristics at varying concentrations. Heat-induced hemolysis and glucose uptake by yeast cells assays were conducted to evaluate these properties. Besides, docking analyses were performed on four molecular targets. These studies were combined with molecular dynamics simulations to elucidate the time-evolving inhibitory effect of selected inhibitors within the active pockets of the target proteins (COX-1 and COX-2). Indanone derivative (10-100 µM) inhibited the lysis of human red blood cells from 9.12 ± 0.75 to 72.82 ± 4.36% and, at 5-100 µM concentrations, it significantly increased the yeast cells' glucose uptake (5.16 ± 1.28% to 76.59 ± 1.62%). Concluding, the isolated indanone might act as an anti-diabetic agent by interacting with critical amino acid residues of 5' adenosine monophosphate-activated protein kinase (AMPK), and it showed a binding affinity with anti-inflammatory targets COX-1, COX-2, and TNF-α. Besides, the obtained results may help to consider the indanone derivative isolated from F. adenophylla as a promising candidate for drug delivery, subject to outcomes of further in vivo and clinical studies.


Subject(s)
Anti-Inflammatory Agents , Cyclooxygenase 2 , Hypoglycemic Agents , Molecular Docking Simulation , Humans , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Cyclooxygenase 2/metabolism , Indans/pharmacology , Indans/chemistry , Cyclooxygenase 1/metabolism , Molecular Dynamics Simulation , Glucose/metabolism , Hemolysis/drug effects , Saccharomyces cerevisiae/metabolism , Plant Extracts/pharmacology , Plant Extracts/chemistry , Erythrocytes/drug effects , Erythrocytes/metabolism , Computer Simulation
15.
Carbohydr Polym ; 336: 122111, 2024 Jul 15.
Article in English | MEDLINE | ID: mdl-38670748

ABSTRACT

The development of a rapid hemostat through a facile method with co-existing antibacterial activity and minimum erythrocyte lysis property stands as a major requirement in the field of hemostasis. Herein, a series of novel microparticle hemostats were synthesized using chitosan, different hydrothermally-treated starches, and cross-linked with tannic acid (TA) simultaneously in an unoxidized environment via ionotropic gelation method. Hemostats' comparative functional properties, such as adjustable antibacterial and erythrocyte compatibility upon various starch additions were evaluated. The in vivo hemostatic study revealed that the developed hemostats for mouse liver laceration and rat tail amputation had clotting times (13 s and 38 s, respectively) and blood loss (51 mg and 62 mg, respectively) similar to those of Celox™. The erythrocyte adhesion test suggested that erythrocyte distortion can be lowered by modifying the antibacterial hemostats with different starches. The broad-spectrum antibacterial efficacy of the hemostats remained intact against S. aureus (>90 %), E. coli (>80 %), and P. mirabilis bacteria upon starch modification. They also demonstrated high hemocompatibility (<3 % hemolysis ratio), moderate cell viability (>81 %), in vivo biodegradation, and angiogenesis indicating adequate biocompatibility and wound healing. The developed hemostats hold significant promise to be employed as rapid hemostatic agents for preventing major bleeding and bacterial infection in emergencies.


Subject(s)
Anti-Bacterial Agents , Chitosan , Hemostatics , Polyphenols , Staphylococcus aureus , Starch , Tannins , Tannins/chemistry , Tannins/pharmacology , Chitosan/chemistry , Chitosan/pharmacology , Starch/chemistry , Starch/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Hemostatics/chemistry , Hemostatics/pharmacology , Mice , Rats , Staphylococcus aureus/drug effects , Hemostasis/drug effects , Escherichia coli/drug effects , Male , Hemolysis/drug effects , Humans , Erythrocytes/drug effects
16.
Cell Mol Biol (Noisy-le-grand) ; 70(3): 29-39, 2024 Mar 31.
Article in English | MEDLINE | ID: mdl-38650159

ABSTRACT

Asthma is a chronic inflammatory disease of the airways strongly associated with interleukin-4 (IL-4), a cytokine that mediates and regulates various immune responses, including allergic reactions. This study aimed to evaluate the anti-inflammatory and antioxidant effects of an Aqueous Extract of Clove (AEC) Syzygium aromaticum on the lungs and erythrocytes of an experimental asthma model in Wistar rats. For this purpose, four groups of male rats were examined: control, sensitized with ovalbumin (OVA), treated with AEC, and treated with a combination of OVA/AEC. After treatment, the antioxidant effect was determined by measuring the malondialdehyde (MDA), glutathione peroxidase (GPx), glutathione (GSH), and catalase (CAT) levels. The anti-inflammatory effect was determined by measuring IL-4 levels by performing enzyme-linked immunosorbent assay (ELISA) using serum, lung, and bronchoalveolar lavage fluid (BALF) samples. A significant reduction (p ≤ 0.05) in the MDA levels and a significant increase (p ≤ 0.05) in the levels of GPx and CAT were observed in the lungs of rats treated with cloves. However, no statistically significant variation was observed in GSH levels. In erythrocytes, no statistically significant differences were observed between the experimental batches. Regarding the anti-inflammatory effect, the administration of S. aromaticum extract to sensitized rats resulted in a recovery in the levels of total proteins and IL-4 and a decrease in the three compartments studied (lungs, serum, and bronchoalveolar liquid). These results were confirmed by microscopic examination of lung histological sections. Overall, these findings confirmed that the AEC has anti-inflammatory and antioxidant effects.


Subject(s)
Anti-Inflammatory Agents , Antioxidants , Asthma , Bronchoalveolar Lavage Fluid , Disease Models, Animal , Glutathione Peroxidase , Glutathione , Interleukin-4 , Lung , Malondialdehyde , Plant Extracts , Rats, Wistar , Syzygium , Animals , Antioxidants/pharmacology , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Syzygium/chemistry , Male , Asthma/drug therapy , Asthma/chemically induced , Asthma/metabolism , Asthma/pathology , Bronchoalveolar Lavage Fluid/chemistry , Lung/drug effects , Lung/pathology , Lung/metabolism , Glutathione Peroxidase/metabolism , Glutathione/metabolism , Interleukin-4/metabolism , Interleukin-4/blood , Malondialdehyde/metabolism , Ovalbumin , Catalase/metabolism , Rats , Erythrocytes/drug effects , Erythrocytes/metabolism , Water/chemistry
19.
Int J Mol Sci ; 25(8)2024 Apr 10.
Article in English | MEDLINE | ID: mdl-38673786

ABSTRACT

Antimicrobial peptides (AMPs) are viewed as potential compounds for the treatment of bacterial infections. Nevertheless, the successful translation of AMPs into clinical applications has been impeded primarily due to their low stability in biological environments and potential toxicological concerns at higher concentrations. The covalent attachment of AMPs to a material's surface has been sought to improve their stability. However, it is still an open question what is required to best perform such an attachment and the role of the support. In this work, six different AMPs were covalently attached to a long-ranged ordered amphiphilic hydrogel, with their antibacterial efficacy evaluated and compared to their performance when free in solution. Among the tested AMPs were four different versions of synthetic end-tagged AMPs where the sequence was altered to change the cationic residue as well as to vary the degree of hydrophobicity. Two previously well-studied AMPs, Piscidin 1 and Omiganan, were also included as comparisons. The antibacterial efficacy against Staphylococcus aureus remained largely consistent between free AMPs and those attached to surfaces. However, the activity pattern against Pseudomonas aeruginosa on hydrogel surfaces displayed a marked contrast to that observed in the solution. Additionally, all the AMPs showed varying degrees of hemolytic activity when in solution. This activity was entirely diminished, and all the AMPs were non-hemolytic when attached to the hydrogels.


Subject(s)
Anti-Bacterial Agents , Hemolysis , Hydrogels , Microbial Sensitivity Tests , Pseudomonas aeruginosa , Staphylococcus aureus , Hydrogels/chemistry , Hydrogels/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Hemolysis/drug effects , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects , Antimicrobial Peptides/chemistry , Antimicrobial Peptides/pharmacology , Humans , Antimicrobial Cationic Peptides/pharmacology , Antimicrobial Cationic Peptides/chemistry , Hydrophobic and Hydrophilic Interactions , Erythrocytes/drug effects
20.
Biochem Biophys Res Commun ; 711: 149912, 2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38615572

ABSTRACT

An accessory gene regulator (agr) in the quorum sensing (QS) system in Staphylococcus aureus contributes to host infection, virulence factor production, and resistance to oxidative damage. Artificially maintaining the inactive state of agr QS impedes the host infection strategy of S. aureus and inhibits toxin production. The QS system performs intercellular signal transduction, which is activated by the mature autoinducer peptide (AIP). It is released from cells after AgrD peptide processing as an intercellular signal associated with increased bacterial cell density. This study evaluated the effectiveness of inhibiting agr QS wherein AIP trap carriers were made to coexist when culturing Staphylococcus aureus. Immersing a nitrocellulose (NC) membrane in Staphylococcus aureus ATCC 12600 culture inhibited QS-dependent α-hemolysin production, which significantly reduced the hemolysis ratio of sheep red blood cells by the culture supernatant. A quartz crystal microbalance analysis supported AIP adsorption onto the NC membrane. Adding the NC membrane during culture was found to maintain the expression levels of the agr QS gene agrA and α-hemolysin gene hla lower than that when it was not added. Eliminating extracellular AIP signals allowed agr QS to remain inactive and prevented QS-dependent α-hemolysin expression. Isolating intercellular signals secreted outside the cell is an effective strategy to suppress gene expression in bacterial cells that collaborate via intercellular signaling.


Subject(s)
Bacterial Proteins , Hemolysin Proteins , Quorum Sensing , Staphylococcus aureus , Staphylococcus aureus/physiology , Staphylococcus aureus/genetics , Staphylococcus aureus/metabolism , Bacterial Proteins/metabolism , Bacterial Proteins/genetics , Hemolysin Proteins/metabolism , Hemolysin Proteins/genetics , Animals , Trans-Activators/metabolism , Trans-Activators/genetics , Hemolysis , Sheep , Gene Expression Regulation, Bacterial , Bacterial Toxins/metabolism , Bacterial Toxins/genetics , Signal Transduction , Erythrocytes/metabolism , Erythrocytes/drug effects , Peptides/pharmacology , Peptides/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...